Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on N Oxidation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel NCS TEMPO oxidation method ensures stable scale-up and high purity for pharmaceutical intermediates manufacturing reducing cost and improving supply chain reliability significantly
Novel four-step route reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing using accessible raw materials.
Patent CN110655480A reveals a green Ru/C-catalyzed oxidation method for sulfones. Achieve near-quantitative yields in water, offering significant cost reduction and supply chain reliability.
Patent CN105693490A reveals advanced cobalt catalyst for TMBQ synthesis. Enhances purity and supply chain stability for vitamin E intermediates.
Novel ruthenium-catalyzed route for Prucalopride intermediate offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing without toxic osmium reagents.
Patent CN113845466A details a mild hypervalent iodine-mediated alpha-oxidation for producing high-purity pharmaceutical intermediates with improved yield and environmental profile.
Novel asymmetric Mannich catalyst synthesis via eco-friendly oxygen oxidation. Delivers high ee values for beta-amino carbonyls. Reliable supply chain solution.
Efficient copper-catalyzed synthesis of quaternary carbon center indolones. Mild conditions, high yield, scalable for pharmaceutical intermediates supply chain.
Patent CN103012085A details a safe, one-step NBS oxidation for benzophenone derivatives, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN106749259B reveals a metal-free synthetic route for CDK4/6 inhibitor intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN109369672B reveals a rapid room-temperature synthesis of cycloheptatriene derivatives using PIDA, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Advanced synthesis of D-B-A binary compounds for organic photovoltaics. Enhances carrier mobility and offers scalable manufacturing solutions for display materials.
Advanced chiral preparation method for Carfilzomib intermediate ensuring high purity and yield. Optimized for commercial scale-up and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN111138429A reveals a mild sodium hypochlorite oxidation route for 1,2,4-triazolopyridines, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel hypervalent iodine route for isocoumarin ethers. High yield, metal-free, scalable process for pharmaceutical intermediates.
Novel route for Cabazitaxel (XRP6258) using DMSO/Acetic Anhydride. High yield, scalable process for pharmaceutical intermediates reducing production costs.
Patent CN107629101B reveals efficient synthesis route. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing supply chain.
Advanced synthesis of sPLA2 inhibitor intermediates via sulfinating agents. Reduces costs and improves yield for pharmaceutical manufacturing supply chains.
Advanced oxidation of industrial fluorene to high-purity 9-fluorenone using air and recyclable solvents for cost-effective manufacturing.
Patent CN110423261B reveals a novel synthesis route for 7-ketolithocholic acid from hyocholic acid, offering high purity and significant cost reduction in bile acid manufacturing.